Synthetic peptides for the immunodiagnosis of human diseasesGOMARA, M. J; HARO, I.Current medicinal chemistry. 2007, Vol 14, Num 5, pp 531-546, issn 0929-8673, 16 p.Article

Interaction of a hepatitis G synthetic peptide antigen with cell membrane lipidsMESTRES, C; ALSINA, M. A; ESPINA, M et al.Recent developments in colloids and interface research (Vol. 2 (2004)). Recent developments in colloids and interface research. 2004, pp 23-33, isbn 81-7895-133-9, 11 p.Book Chapter

Conformational study of HGV-NS3 (440-460) by circular dichroism (CD). Effect of lipophillic derivation on CD spectraROJO, N; ALSINA, M. A; HARO, I et al.Journal de physique. IV. 2001, Vol 90, pp 233-235, issn 1155-4339Article

Study at the air/water interface of a hepatitis A N-acetylated and C-amidated synthetic peptide (AcVP3(110-121)-NH₂). II. Miscibility in lipid monolayersSOSPEDRA, P; ESPINA, M; GOMARA, M. J et al.Journal of colloid and interface science. 2001, Vol 244, Num 1, pp 87-96, issn 0021-9797Article

Solid phase synthesis of potential antigenic peptides and new lipopeptides of hepatitis B virusRABANAL, F; HARO, I; REIG, F et al.Journal of the Chemical Society. Perkin transactions. I. 1991, Num 4, pp 945-952, issn 0300-922X, 8 p.Article

Gentamicin determination in biological fluids by HPLC, using tobramycin as internal standardCABANES, A; CAJAL, Y; HARO, I et al.Journal of liquid chromatography. 1991, Vol 14, Num 10, pp 1989-2010, issn 0148-3919Article

A synthetic glycopeptide of substance P analogue (SP_6-11) with enhanced NK-1 receptor specificityHARO, I; BUSQUETS, M. A; TORRES, J. L et al.Journal of pharmaceutical sciences. 1990, Vol 79, Num 1, pp 74-76, issn 0022-3549Article

Continuous-flow solid-phase synthesis of potential antigenic peptides of hepatitis B virusRABANAL, F; HARO, I; REIG, F et al.International journal of peptide & protein research. 1990, Vol 36, Num 1, pp 26-30, issn 0367-8377Article

Mixed monolayers composed of PC/PS/Chol. Interaction with opioid moleculesREIG, F; MESTRES, C; HARO, I et al.Colloid and polymer science (Print). 1989, Vol 267, Num 2, pp 139-144, issn 0303-402XArticle

Physicochemical study of a synthetic peptide belonging to human filaggrin proteinPEREZ, T; MUNOZ, M; JOUHER, Y et al.Journal de physique. IV. 2001, Vol 90, pp 261-263, issn 1155-4339Article

Physicochemical interaction of a lipophilic derivative of HAV antigen VP3(110-121) with lipid monolayersSOSPEDRA, P; HARO, I; ALSINA, M. A et al.Materials science & engineering. C, Biomimetic materials, sensors and systems. 1999, Vol 8-9, pp 543-549, issn 0928-4931Conference Paper

A new continuous epitope of hepatitis A virusBOSCH, A; GONZALEZ-DANKAART, J. F; HARO, I et al.Journal of medical virology. 1998, Vol 54, Num 2, pp 95-102, issn 0146-6615Article

Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101-121) synthetic peptideMUNOZ, M; GARCIA, M; REIG, F et al.Analyst (London. 1877. Print). 1998, Vol 123, Num 11, pp 2223-2228, issn 0003-2654Conference Paper

Physicochemical study of several peptide constructs based on the sequence (96-107) of VP2-HAV proteinMOTA, F. M; BUSQUETS, M. A; REIG, F et al.Journal of colloid and interface science. 1997, Vol 188, Num 1, pp 81-93, issn 0021-9797Article

Interaction of the hepatitis A peptide VP3(110-121) with lipid mono and bilayer models of cellular membranesMESTRES, C; PEREZ, J. A; REIG, F et al.Colloid and polymer science (Print). 1997, Vol 275, Num 10, pp 946-952, issn 0303-402XArticle

Solid-phase synthesis of the exposed capsid peptide VP2(96-107) of the hepatitis A virus. Study of its physicochemical interactions with phospholipidsHARO, I; PEREZ, J. A; REIG, F et al.Langmuir. 1996, Vol 12, Num 21, pp 5120-5125, issn 0743-7463Article

Interaction of enrofloxacin with phospholipid mono- and bilayersMESTRES, C; ALSINA, M. A; BUSQUETS, M. A et al.Langmuir. 1994, Vol 10, Num 3, pp 767-772, issn 0743-7463Article

Interaction of aminoglycosides and colistin with model membranes : liposomes and monolayersCOLOME, C; ALSINA, M. A; BUSQUETS, M. A et al.International journal of pharmaceutics. 1993, Vol 90, Num 1, pp 59-71, issn 0378-5173Article

Surface behaviour and peptide-lipid interactions of the E1(3-17)R and E1(3-17)G peptides from El capside protein of GBV-C/HGV virusFONTVILA, O; MESTRES, C; MUNOZ, M et al.Colloids and surfaces. A, Physicochemical and engineering aspects. 2008, Vol 321, Num 1-3, pp 175-180, issn 0927-7757, 6 p.Conference Paper

The covalent coupling of HAV-VP3 (110-121) synthetic peptide to liposomes: physicochemical studiesMUNOZ, M; SOSPEDRA, P; GOMARA, M. J et al.International journal of pharmaceutics. 2004, Vol 269, Num 1, pp 177-184, issn 0378-5173, 8 p.Article

Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniquesGARCIA, M; PUJOL, M; REIG, F et al.Analyst (London. 1877. Print). 1996, Vol 121, Num 11, pp 1583-1588, issn 0003-2654Conference Paper

Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptideHARO, I; PINTO, R. M; GONZALEZ-DANKAART, J. F et al.Microbiology and immunology. 1995, Vol 39, Num 7, pp 485-490, issn 0385-5600Article

Analysis of the perturbation of phospholipid model membranes by a multiple antigenic peptideHARO, I; BUSQUETS, M. A; ORTIZ, A et al.Analytica chimica acta. 1995, Vol 303, Num 1, pp 57-64, issn 0003-2670Conference Paper

Synthesis and physicochemical study of hepatitis A viral-VP1 protein peptidesMARTIN, I; HARO, I; FEIG, F et al.Langmuir. 1994, Vol 10, Num 3, pp 784-789, issn 0743-7463Article

Physicochemical study of hepatitis A and B peptide fragments with monolayers as membrane modelsBUSQUETS, M. A; RABANAL, F; HARO, I et al.Journal of colloid and interface science. 1992, Vol 152, Num 1, pp 54-59, issn 0021-9797Article